We present a rare case of a 42-year-old man with a long history of von Hippel–Lindau disease that was scanned with 68Ga-DOTA-TOC PET/CT for suspicion of disease relapse. 68Ga-DOTA-TOC imaging demonstrated increased DOTA-TOC uptake in pancreas tail and intramedullary and extramedullary spinal hemangioblastomas, only some of which have already been highlighted at MRI examination. This case illustrates the significant role the 68Ga-labeled somatostatin receptor analogs PET/CT in the management of the von Hippel–Lindau disease.
From the Divisions of *Nuclear Medicine, and
†Endocrinology, Diabetology, and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
Received for publication June 27, 2018; revision accepted October 13, 2018.
Conflicts of interest and sources of funding: none declared.
Correspondence to: Désirée Deandreis, MD, AP, Division of Nuclear Medicine, Department of Medical Sciences, University of Turin, Corso Bramante 88, 10126 Turin, Italy. E-mail: firstname.lastname@example.org.